» Articles » PMID: 14728724

Identification of a Novel Gene Family That Includes the Interferon-inducible Human Genes 6-16 and ISG12

Overview
Journal BMC Genomics
Publisher Biomed Central
Specialty Genetics
Date 2004 Jan 20
PMID 14728724
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The human 6-16 and ISG12 genes are transcriptionally upregulated in a variety of cell types in response to type I interferon (IFN). The predicted products of these genes are small (12.9 and 11.5 kDa respectively), hydrophobic proteins that share 36% overall amino acid identity. Gene disruption and over-expression studies have so far failed to reveal any biochemical or cellular roles for these proteins.

Results: We have used in silico analyses to identify a novel family of genes (the ISG12 gene family) related to both the human 6-16 and ISG12 genes. Each ISG12 family member codes for a small hydrophobic protein containing a conserved ~80 amino-acid motif (the ISG12 motif). So far we have detected 46 family members in 25 organisms, ranging from unicellular eukaryotes to humans. Humans have four ISG12 genes: the 6-16 gene at chromosome 1p35 and three genes (ISG12(a), ISG12(b) and ISG12(c)) clustered at chromosome 14q32. Mice have three family members (ISG12(a), ISG12(b1) and ISG12(b2)) clustered at chromosome 12F1 (syntenic with human chromosome 14q32). There does not appear to be a murine 6-16 gene. On the basis of phylogenetic analyses, genomic organisation and intron-alignments we suggest that this family has arisen through divergent inter- and intra-chromosomal gene duplication events. The transcripts from human and mouse genes are detectable, all but two (human ISG12(b) and ISG12(c)) being upregulated in response to type I IFN in the cell lines tested.

Conclusions: Members of the eukaryotic ISG12 gene family encode a small hydrophobic protein with at least one copy of a newly defined motif of approximately 80 amino-acids (the ISG12 motif). In higher eukaryotes, many of the genes have acquired a responsiveness to type I IFN during evolution suggesting that a role in resisting cellular or environmental stress may be a unifying property of all family members. Analysis of gene-function in higher eukaryotes is complicated by the possibility of functional redundancy between family-members. Genetic studies in organisms (e.g. Dictyostelium discoideum) with just one family member so far identified may be particularly helpful in this respect.

Citing Articles

SARS-CoV-2 infection of human pluripotent stem cell-derived vascular cells reveals smooth muscle cells as key mediators of vascular pathology during infection.

Richards A, Khalil A, Friesen M, Whitfield T, Gao X, Lungjangwa T Nat Commun. 2024; 15(1):10754.

PMID: 39737992 PMC: 11685814. DOI: 10.1038/s41467-024-54917-4.


SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infections.

Rosenheim J, Gupta R, Thakker C, Mann T, Bell L, Broderick C Nat Commun. 2024; 15(1):10434.

PMID: 39616162 PMC: 11608262. DOI: 10.1038/s41467-024-54764-3.


Single-cell analysis reveals lasting immunological consequences of influenza infection and respiratory immunization in the pig lung.

Muir A, Paudyal B, Schmidt S, Sedaghat-Rostami E, Chakravarti S, Villanueva-Hernandez S PLoS Pathog. 2024; 20(7):e1011910.

PMID: 39024231 PMC: 11257366. DOI: 10.1371/journal.ppat.1011910.


ISG12a promotes immunotherapy of HBV-associated hepatocellular carcinoma through blocking TRIM21/AKT/β-catenin/PD-L1 axis.

Deng R, Tian R, Li X, Xu Y, Li Y, Wang X iScience. 2024; 27(4):109533.

PMID: 38591006 PMC: 11000115. DOI: 10.1016/j.isci.2024.109533.


Chicken IFI6 inhibits avian reovirus replication and affects related innate immune signaling pathways.

Wan L, Wang S, Xie Z, Ren H, Xie L, Luo S Front Microbiol. 2023; 14:1237438.

PMID: 38033564 PMC: 10687481. DOI: 10.3389/fmicb.2023.1237438.


References
1.
Gjermandsen I, Justesen J, Martensen P . The interferon-induced gene ISG12 is regulated by various cytokines as the gene 6-16 in human cell lines. Cytokine. 2000; 12(3):233-8. DOI: 10.1006/cyto.1999.0549. View

2.
Kerr I, Brown R . pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc Natl Acad Sci U S A. 1978; 75(1):256-60. PMC: 411225. DOI: 10.1073/pnas.75.1.256. View

3.
Davis G, BALART L, Schiff E, Lindsay K, Bodenheimer Jr H, Perrillo R . Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med. 1989; 321(22):1501-6. DOI: 10.1056/NEJM198911303212203. View

4.
Malik U, Makower D, Wadler S . Interferon-mediated fatigue. Cancer. 2001; 92(6 Suppl):1664-8. DOI: 10.1002/1097-0142(20010915)92:6+<1664::aid-cncr1494>3.0.co;2-9. View

5.
Berry M, Knutson G, Lasky S, Munemitsu S, Samuel C . Mechanism of interferon action. Purification and substrate specificities of the double-stranded RNA-dependent protein kinase from untreated and interferon-treated mouse fibroblasts. J Biol Chem. 1985; 260(20):11240-7. View